29th Annual Conference on Mammography and Other Breast Imaging

Dates and Times

Start: 10/14/2017 7:00 AM
End: 10/14/2017 5:00 PM

Objectives

• Compare and contrast image acquisition techniques for standard digital mammography vs breast tomosynthesis.
• Outline expected changes in cancer detection and recall rates from screening mammography after implementation of breast tomosynthesis based on clinical trials and observational studies.
• Describe strategies for dose reduction in breast tomosynthesis.
• Outline evidence for using tomosynthesis rather than additional conventional mammographic views for evaluation mass margins.
• Outline approaches for biopsy of tomosynthesis findings occult on 2D mammography.
• Outline considerations for measuring and reporting findings seen on tomosynthesis imaging.
• Describe how axillary nodal status, tumor size and tumor grade correlate with prognosis for invasive breast cancer.
• Outline the histologic subtypes of invasive ductal carcinoma and describe their unique imaging features.
• Describe the clinical and imaging presentation of invasive lobular carcinoma and identify strategies that can be utilized to maximize detection of this specific malignancy.
• Outline evidence for the in-situ to invasive carcinoma sequence in breast cancer pathogenesis.
• Describe principles for treating DCIS in the breast based on patient and tumor characteristics.
• Summarize arguments for and against treating LCIS.
• Describe the performance of breast MRI for identifying additional sites of occult carcinoma in women with newly diagnosed breast cancer.
• Describe the positive predictive value of MRI guided-biopsy for suspicious findings seen on breast MRI.
• Outline appropriate criteria for selecting women for supplemental screening using breast MRI.
• Identify the characteristics that safely allow a mammographic lesion to be classified as probably benign.
• Describe the features of a solid mass seen on ultrasound that allow it to be followed as probably benign.
• Describe features of probably benign lesions in follow up by mammography or ultrasound that should prompt biopsy.
• List the elements used to define negligence in medical malpractice.
• Describe the role of the medical expert in establishing the standard of care in medical malpractice litigation.
• Outline strategies for optimizing communication and documentation in patient care.
• Describe the role of breast density in breast cancer risk.
• Describe the current state of breast density notification legislation.
• Outline strategies for maximizing breast cancer detection at screening for women with dense breasts.
• Outline current guidelines and rationale for mammographic screening put forward by the United States Preventative Services Task Force.
• Outline current guidelines and rationale for mammographic screening put forward by the American Cancer Society.
• Outline strategies for using performance benchmarks from tomosynthesis implementation to address concerns for harm/benefit analysis in mammographic screening in clinical practice.